I'm looking for

All Resources

Statement of the Society of Gynecologic Oncology to the Food and Drug Administration’s Obstetrics and Gynecology Medical Devices Advisory Committee Concerning Safety of Laparoscopic Power Morcellation

StatementsMorcellation
Apr 1, 2014
Advertisement

Advertise With Us
Related Resources
Dec 9, 2022Summary: Revisions to FDA Approvals for PARP Inhibitors in the Management of Ovarian Cancer
May 29, 2020Wellness Task Force Commitment Statement
Jul 25, 2018Recent Drug Approvals in Gynecologic Oncology: A Statement from SGO’s Communications and Clinical Practice Committees (July, 2018)
Apr 1, 2014Statement of the Society of Gynecologic Oncology to the Food and Drug Administration’s Obstetrics and Gynecology Medical Devices Advisory Committee Concerning Safety of Laparoscopic Power Morcellation